FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)

View source ↗

Summary

The FDA approved a supplemental application for QBREXZA (glycopyrronium) submitted by Journey Medical Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axillary Hyperhidrosis
• Hyperhidrosis

Drugs mentioned

• Qbrexza (glycopyrronium tosylate)

Snippet

SUPPL AP for QBREXZA (GLYCOPYRRONIUM)